THC Relative Valuation
THC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, THC is overvalued; if below, it's undervalued.
Historical Valuation
Tenet Healthcare Corp (THC) is now in the Fair zone, suggesting that its current forward PE ratio of 13.79 is considered Fairly compared with the five-year average of 11.29. The fair price of Tenet Healthcare Corp (THC) is between 130.66 to 180.08 according to relative valuation methord.
Relative Value
Fair Zone
130.66-180.08
Current Price：176.50
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.85
P/B
Median3y
4.51
Median5y
16.68
8.80
FCF Yield
Median3y
11.61
Median5y
23.21
Competitors Valuation Multiple
The average P/S ratio for THC's competitors is 0.92, providing a benchmark for relative valuation. Tenet Healthcare Corp Corp (THC) exhibits a P/S ratio of 0.76, which is -17.46% above the industry average. Given its robust revenue growth of -2.70%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Tenet Healthcare Corp (THC) currently overvalued or undervalued?
What is Tenet Healthcare Corp (THC) fair value?
How does THC's valuation metrics compare to the industry average?
What is the current P/B ratio for Tenet Healthcare Corp (THC) as of Jul 18 2025?
What is the current FCF Yield for Tenet Healthcare Corp (THC) as of Jul 18 2025?
What is the current Forward P/E ratio for Tenet Healthcare Corp (THC) as of Jul 18 2025?